David Protein remains privately held. Its most recent disclosed valuation is $725M. No public ticker exists for the company.
1 valuation. The latest, $725M post-money, was set by the Series A in May 2025.
GreenoaksLEADPPeter RahalLEADGGreenoaks Capital PartnersHHG VenturesGreenoaksPeter RahalDavid, sold as David Protein, is a New York City high-protein food brand founded in 2024 by Peter Rahal, the co-founder of RXBAR, and Zach Ranen. Its first product, a protein bar with 28 grams of protein and 150 calories, launched in September 2024, and the lineup has since grown to include protein shakes, milkshakes and a frozen dessert sold in pint cartons with 30 grams of protein per serving. The brand's formulations rely on esterified propoxylated glycerol, a fat substitute David gained exclusive control of in 2025 by buying its sole manufacturer, Epogee. Products are third-party tested for protein content and purity, and the brand is named after Michelangelo's statue of David.
David raised a $75 million Series A round in May 2025 at a reported $725 million valuation, backed by Greenoaks Capital Partners, HG Ventures and Valor Equity Partners.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds David Protein.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. David Protein availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — David Protein included.
No. David Protein is a private company; its shares do not trade on a public exchange.
The last valuation is $725M.
Lead investors for each round are in the funding timeline.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
